2022
DOI: 10.3390/molecules27020383
|View full text |Cite
|
Sign up to set email alerts
|

Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases

Abstract: Aptamers are RNA/DNA oligonucleotide molecules that specifically bind to a targeted complementary molecule. As potential recognition elements with promising diagnostic and therapeutic applications, aptamers, such as monoclonal antibodies, could provide many treatment and diagnostic options for blood diseases. Aptamers present several superior features over antibodies, including a simple in vitro selection and production, ease of modification and conjugation, high stability, and low immunogenicity. Emerging as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
27
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 115 publications
0
27
0
Order By: Relevance
“…Aptamers have been employed in biosensing and biomedical applications [ 43 , 44 ]. Regarding the latter, their use in medical imaging, diagnosis and treatment of diseases, targeted drug delivery, and regenerative medicine have already been described [ 44 , 45 , 46 , 47 , 48 ]. As far as biosensing applications are concerned, aptamers are used as recognition and binding elements.…”
Section: Surface-residing Molecular Targetsmentioning
confidence: 99%
“…Aptamers have been employed in biosensing and biomedical applications [ 43 , 44 ]. Regarding the latter, their use in medical imaging, diagnosis and treatment of diseases, targeted drug delivery, and regenerative medicine have already been described [ 44 , 45 , 46 , 47 , 48 ]. As far as biosensing applications are concerned, aptamers are used as recognition and binding elements.…”
Section: Surface-residing Molecular Targetsmentioning
confidence: 99%
“…High specificity for targets has made aptamers an attractive tool in biomedical applications like diagnostics, imaging, and therapeutics (Barbas et al, 2010; Liu et al, 2012). The prospects of aptamers for clinical application are recently reviewed by many authors (Aljohani et al, 2022; Devi et al, 2021; Liu et al, 2022). They are studied as delivery agents incorporated into constructs that can carry therapeutic payload like siRNA, chemotherapeutic agents, cell toxins, and nanoparticles (Barbas et al, 2010).…”
Section: Rna Interferencementioning
confidence: 99%
“…Several aspects of aptamers are superior to antibodies; for example, aptamers are easier to obtain, are less expensive to produce, and exhibit better biocompatibility (Byun 2021). Aptamers are widely used in various biomedical elds, including therapeutics, biosensors, diagnostics, drug delivery and imaging systems (Odeh et al 2019;Aljohani et al 2022). However, aptamers are susceptible to degradation by nucleases, which severely limits their application in biological uids (Daniel et al 2004).…”
Section: Introductionmentioning
confidence: 99%